CClinicalTrials.gg
CompletedNCT03973606Updated Dec 22, 2025

Assessment of the Health Literacy Among Arab Women in East Jerusalem

An interventional study of Heath literacy assessment in Arab women in East Jerusalem in Health Literacy and Cardiovascular Diseases, sponsored by Hadassah Medical Organization. Completed at 1 site in Israel. Open to female participants aged 18 Years to 85 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-12-22.

Sponsored by Hadassah Medical Organization · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
306
Allocation
Non-randomized
Ages
18 Years to 85 Years
Sex
Female
01

Study summary

This is a two-stage study: The objective of the first stage is to explore health literacy (HL) needs and preferences of Arab women through conducting Focus Group Discussions (FGDs).

The second stage will employ conducting a HL intervention tailored to the participants' needs and preferences as presented in the FGDs. Objectives include increasing the percentage of women who utilize patient-doctor communication skills and increasing their cardiovascular disease (CVD) knowledge.The intervention consists of four sessions that will be conducted in municipality-sponsored women's groups in Jerusalem and other Arab communities. Questionnaires will be completed before and three months after the intervention. The study answers the following: Can HL workshops improve patient-doctor communication skills and CVD knowledge in Arab women.

Read the detailed description

Arab women in Israel are at high risk of low health literacy due to lower levels of education and low socio-economic status. Health literacy (HL) refers to the skills and competencies enabling people to obtain and interpret health information and apply their knowledge to inform health-related decision-making. It's also defined as "the degree to which individuals have the capacity to obtain, understand, and process basic health information and services needed to make appropriate health decisions".

The objective of the first stage of the study is to explore health literacy needs and preferences of Arab women through conducting Focus Group Discussions (FGDs) with women in East Jerusalem. Six different focus groups will be conducted at three of the six municipality community centers in East Jerusalem. Participants will be recruited through identified community centers.

Each group will meet once for up to two hours. The study will be explained to them by an investigator who has been trained in the administration of focus groups, and they will be asked to sign a consent form. Discussions will be recorded without the names of the participants (they will be instructed not to use their names once the recording begins). At the end of the meeting, each participant will receive a bag and pamphlets with information regarding women's health.

The second stage will employ conducting a HL intervention tailored to the participants' needs and preferences as presented in the FGDs. Objectives include increasing the percentage of women who utilize patient-doctor communication skills and increasing their cardiovascular disease (CVD) knowledge.The intervention consists of four sessions that will be conducted in municipality-sponsored women's groups in Jerusalem and other Arab communities. Questionnaires will be completed before and three months after the intervention. The study answers the following: Can HL workshops improve patient-doctor communication skills and CVD knowledge in Arab women.

02

Conditions studied

  • Health Literacy
  • Cardiovascular Diseases

Keywords

  • Health literacy
  • East Jerusalem
  • Focus groups
  • Arabic Women
03

In context

Cardiovascular Diseases

4,904 studies on the registry are indexed under Cardiovascular Diseases; 919 are open to participants now.

This study's enrollment of 306 is above the median of 100 across 2,738 interventional studies indexed under Cardiovascular Diseases.

Browse Cardiovascular Diseases studies →

Lead sponsor

Hadassah Medical Organization is the lead sponsor of 659 studies on the registry; 54 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 85 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • All women aged 18-85 that attend and participate in the community's women's groups
  • They must speak Arabic

Exclusion criteria

Exclusion Criteria:

  • Not in the age range of 18-85.
  • Do not speak Arabic.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Non-randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
306 participants (actual)

Study arms

  • No intervention
    Arab Women health literacy focus groups

    Arab women in East Jerusalem will be part of focus groups. During the focus groups, a set of pre-prepared questions will be presented to the participants. The focus groups will be recorded and analyzed verbatim.

  • Experimental
    Health literacy workshop

    Women from East-Jerusalem and other Arab communities in Israel will be invited to participate in a 4-sessions workshop designed to improve health literacy, self-efficacy when interacting with their physician and increase their cardiovascular health knowledge.

    Other: Heath literacy assessment in Arab women in East Jerusalem

Interventions

  • OtherHeath literacy assessment in Arab women in East Jerusalem

    A 4-sessions intervention to increase the participant's self-efficacy when interacting with their physician and increase their cardiovascular health knowledge.

    Also known as: Health literacy workshop

06

What researchers measure

Primary outcomes

  1. assessment of health literacy level and elucidate factors that will improve health literacy (barriers, incentives, etc.…) among Arab women in East Jerusalem

    The assessment will be done through conduction of focus groups. Focus groups will be audio- recorded, transcribed and analyzed using Systematic text condensation, a descriptive and explorative analysis strategy. Which consists of four steps: 1) total impression - from chaos to themes; 2) identifying and sorting meanings units - from themes to codes; 3) condensation - from code to meaning; 4) synthesizing - from condensation to descriptions and concepts. It is expected that six focus groups will be sufficient to achieve saturation of themes. If results are not sufficient, investigators will ask to increase the number of focus groups.

    Time frame: within 6 months

  2. Change in cardiovascular disease knowledge

    A self report questionnaire based on the American Heart Association's Cardiovascular, and assess the knowledge regarding heart attack symptoms, by answering yes/no to each item.

    Time frame: At baseline and three months after intervention

  3. Change in perceived efficacy in patient-physician interaction

    Will be assessed using the 10-item Perceived Efficacy in Patient-Physician Interaction (PEPPI) (Maly, Frank, Marshall, Diametteo, Reuben, 1998). Participants respond to each question on a scale of 1 to 10, with 10 representing "very confident,'' and 1 representing "not at all confident". Higher scores represent positive outcome.

    Time frame: At baseline and three months after intervention

  4. Change in remembering doctor's recommendations and reading blood test results

    A 2-item version derived from the Perceived Efficacy in Patient-Physician Interaction (PEPPI). Participants respond to each question on a scale of 1 to 5, with 5 representing "very confident,'' and 1 representing "not at all confident". Higher scores represent positive outcome.

    Time frame: At baseline and three months after intervention

  5. change in health literacy

    Will be assessed using the Health Literacy Survey-Europe-Q16 (HLS-EU-Q16) a 16 question research instrument adapted for use in Israel. Participants respond to each question on a scale of 1 to 4, with 4 representing "fairly easy,'' and 1 representing "very difficult". Higher scores represent positive outcome.

    Time frame: At baseline and three months after intervention

  6. Change in preparation for doctor's visit

    A 6-item questionnaire represents preferred actions that participant\\pants do before their doctor appointment. The more items are selected, the higher the score is, hence representing a positive outcome.

    Time frame: At baseline and three months after intervention

Secondary outcomes

  1. Change in Self-Rated Status of Health (SRH)

    A validated single item health measure in which participants rate the current status of their own health on a five-point scale, from excellent to poor

    Time frame: At baseline and three months after intervention

  2. Change in perceived efficacy in reading and understanding the instruction for taking medications

    Participants will be asked "how confident do you feel you are able to follow the instructions on the label of a medication bottle?"

    Time frame: At baseline and three months after intervention

07

Study locations

1 site
  • Beit-Safafa community center
    Jerusalem, 95822, Israel
08

References and documents

Publications

  • Maly RC, Frank JC, Marshall GN, DiMatteo MR, Reuben DB. Perceived efficacy in patient-physician interactions (PEPPI): validation of an instrument in older persons. J Am Geriatr Soc. 1998 Jul;46(7):889-94. doi: 10.1111/j.1532-5415.1998.tb02725.x. PubMed 9670878 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 22, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03973606
Lead sponsor
Hadassah Medical Organization
Responsible party
Donna R Zwas (Director of Linda Joy Pollin Cardiovascular Wellness Center for Women, Hadassah Medical Organization) — Principal investigator
First posted
Jun 4, 2019
Start date
Jul 30, 2020
Primary completion
Sep 30, 2023
Completion
Sep 30, 2023
Last update
Dec 22, 2025

Study contacts

Donna Zwas, MD MPH
principal investigator · Hadassah Medical Organization

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion